BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2176889)

  • 1. Patterns of strongly protein-associated simian virus 40 DNA replication intermediates resulting from exposures to specific topoisomerase poisons.
    Shin CG; Snapka RM
    Biochemistry; 1990 Dec; 29(49):10934-9. PubMed ID: 2176889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
    Wong ML; Hsu MT
    J Virol; 1990 Feb; 64(2):691-9. PubMed ID: 2153235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DA-125, a new antitumor agent, inhibits topoisomerase II as topoisomerase poison and DNA intercalator simultaneously.
    Seo J; Lee HS; Lee M; Kim M; Shin CG
    Arch Pharm Res; 2004 Jan; 27(1):77-82. PubMed ID: 14969343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA.
    Levac P; Moss T
    Chromosoma; 1996 Oct; 105(4):250-60. PubMed ID: 8854885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication.
    Snapka RM
    NCI Monogr; 1987; (4):55-60. PubMed ID: 2819732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication.
    Snapka RM
    Mol Cell Biol; 1986 Dec; 6(12):4221-7. PubMed ID: 3025645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swiveling and decatenation of replicating simian virus 40 genomes in vivo.
    Snapka RM; Powelson MA; Strayer JM
    Mol Cell Biol; 1988 Feb; 8(2):515-21. PubMed ID: 2832724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ICRF-193, a novel DNA topoisomerase II inhibitor, on simian virus 40 DNA and chromosome replication in vitro.
    Ishimi Y; Ishida R; Andoh T
    Mol Cell Biol; 1992 Sep; 12(9):4007-14. PubMed ID: 1324412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks.
    Avemann K; Knippers R; Koller T; Sogo JM
    Mol Cell Biol; 1988 Aug; 8(8):3026-34. PubMed ID: 2850477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to camptothecin breaks leading and lagging strand simian virus 40 DNA replication forks.
    Shin CG; Snapka RM
    Biochem Biophys Res Commun; 1990 Apr; 168(1):135-40. PubMed ID: 2158312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of VM26 (teniposide), a specific inhibitor of type II DNA topoisomerase, on SV40 DNA replication in vivo.
    Richter A; Strausfeld U; Knippers R
    Nucleic Acids Res; 1987 Apr; 15(8):3455-68. PubMed ID: 3033604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin.
    Hsiang YH; Lihou MG; Liu LF
    Cancer Res; 1989 Sep; 49(18):5077-82. PubMed ID: 2548710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SV40 DNA replication intermediates: analysis of drugs which target mammalian DNA replication.
    Snapka RM; Permana PA
    Bioessays; 1993 Feb; 15(2):121-7. PubMed ID: 8385943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinobenoxazines: a class of novel antitumor quinolones and potent mammalian DNA topoisomerase II catalytic inhibitors.
    Permana PA; Snapka RM; Shen LL; Chu DT; Clement JJ; Plattner JJ
    Biochemistry; 1994 Sep; 33(37):11333-9. PubMed ID: 7727384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase I is preferentially associated with isolated replicating simian virus 40 molecules after treatment of infected cells with camptothecin.
    Champoux JJ
    J Virol; 1988 Oct; 62(10):3675-83. PubMed ID: 2843668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of DNA synthesis and DNA fragmentation in stimulated splenocytes by the concerted action of topoisomerase I and II poisons.
    Taudou G; Portemer C; Jaxel C; Duguet M
    Biochem Pharmacol; 1993 Jan; 45(2):331-7. PubMed ID: 8382059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of VM26, a specific inhibitor of type II DNA topoisomerase, on SV40 chromatin replication in vitro.
    Richter A; Strausfeld U
    Nucleic Acids Res; 1988 Nov; 16(21):10119-29. PubMed ID: 2848217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a camptothecin-resistant human DNA topoisomerase I in an in vitro system for Simian virus 40 DNA replication.
    Ishimi Y; Nishizawa M; Andoh T
    Eur J Biochem; 1991 Dec; 202(3):835-9. PubMed ID: 1662615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase II inhibitors influence simian virus 40 chromatin structure in vivo accompanied with inhibition of replication, transcription and changes in DNA supercoiling.
    Waldeck W; Zentgraf H; Rösl F
    Oncology; 1988; 45(2):107-16. PubMed ID: 2832799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
    D'Arpa P; Beardmore C; Liu LF
    Cancer Res; 1990 Nov; 50(21):6919-24. PubMed ID: 1698546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.